FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to ophthalmology. A pharmaceutical composition is applicable in ophthalmology and contains the non-steroid anti-inflammatory drug indometacin and a phospholipid agent of the nanoparticle size 10-30 nm herbal phosphatidylcholine, maltose in the following proportions, wt %: phosphatidylcholine 20-43, maltose 55-78, indometacin 2-8. The indometacin and soya phospholipid composition represents a lyophilised powder.
EFFECT: invention provides prolonged storage stability of the composition.
2 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BASED ON BOTANICAL PHOSPHOLIPIDS NANOSYSTEM FOR ACTUATION OF BIOLOGICALLY ACTIVE COMPOUNDS, AND METHOD OF ITS MANUFACTURE (VERSIONS) | 2009 |
|
RU2391966C1 |
| COMPOSITION FOR DRUG SUBSTANCE INTEGRATION INTO LIPID MATRIX, DRUG COMPOSITION WITH PHOSPHOLIPID FATTY ACID SYSTEM AND METHOD FOR PREPARING THEM | 2011 |
|
RU2463056C1 |
| PHARMACEUTIC COMPOSITION INCLUDING ARBIDOL IN COMPOSITION OF PHOSPHOLIPID NANOPARTICLES | 2009 |
|
RU2411942C2 |
| PHARMACEUTICAL COMPOSITION OF INDOMETACIN INCLUDED IN PHOSPHOLIPID NANOPARTICLES FOR TREATING RHEUMATIC AND INFLAMMATORY DISEASES | 2009 |
|
RU2417079C1 |
| PHARMACEUTICAL COMPOSITION BASED ON DOXORUBICINE AND PHOSPHOLIPID NANOPARTICLES FOR TREATMENT OF ONCOLOGIC DISEASES | 2009 |
|
RU2411935C1 |
| COMPOSITION OF DIHYDROQUERCETINE ENCLOSED IN PHOSPHOLIPID NANOPARTICLES | 2013 |
|
RU2536208C1 |
| PHARMACEUTICAL COMPOSITION BASED ON GLUCOCORTICOSTEROID BUDESONIDE AND PHOSPHATIDYLCHOLINE FOR DRY INHALATION | 2019 |
|
RU2730488C1 |
| PHOSPHOLIPID COMPOSITION OF DOXORUBICIN FOR TREATING PATIENTS WITH BREAST CANCER | 2019 |
|
RU2714137C1 |
| LIPID DERIVATIVE OF SARCOLYSIN IN THE COMPOSITION OF PHOSPHOLIPID NANOPARTICLES | 2017 |
|
RU2662086C1 |
| BIS-NAPHTHAZARIN BASED AGENT AND METHOD FOR PRODUCTION THEREOF | 2016 |
|
RU2669374C2 |
